Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue
hypoperfusion that may result in end-organ dysfunction and death. CS is associated with …

Cardiogenic shock is a complex and diverse pathological condition characterized by
reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve …

In recent years, there have been significant advancements in the understanding, risk-
stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and …

Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS)
is crucial in achieving the best possible outcome. Monitoring is a continuous and labour …

Cardiogenic shock (CS) is a life-threatening condition characterized by a state of inadequate
systemic tissue perfusion caused by cardiac dysfunction. When to implement, change, or …

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a
broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS …

Persons with heart failure (HF) often suffer from poor symptom control, decreased quality of
life, and poor communication with their health care providers. These needs are particularly …

Extracorporeal membrane oxygenation (ECMO) is frequently used during lung
transplantation. Unfractionated heparin (UFH) is mainly used as part of ECMO support for …

The care for lung transplantation patients is a complex, multidisciplinary coordination of
physician and non-physician teams throughout the perioperative period. The diversity of …

Aims Artificial intelligence (AI) has emerged as a potential useful tool to support clinical
treatment of heart failure, including the setting of mechanical circulatory support (MCS) …